Quick Answer
TuHURA Biosciences, Inc./NV reported Net Income of -$30.05 million for fiscal year 2025.
TuHURA Biosciences, Inc./NV Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$30.05M | -38.6% |
| 2024 | -$21.68M | -160.6% |
| 2024 | -$8.32M | +71.6% |
| 2023 | -$29.32M | -100.1% |
| 2023 | -$14.65M | +35.4% |
| 2022 | -$22.66M | +40.8% |
| 2021 | -$38.30M | -319.7% |
| 2020 | -$9.13M | -13.4% |
| 2019 | -$8.05M | -172.3% |
| 2018 | $11.14M | +37.8% |
| 2017 | $8.08M | -8.8% |
| 2016 | $8.86M | +284.8% |
| 2015 | -$4.80M | -253.3% |
| 2014 | $3.13M | +137.7% |
| 2013 | -$8.29M | -245.4% |
| 2012 | -$2.40M | -80.1% |
| 2011 | -$1.33M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$7.10M | -27.3% | +25.4% |
| June 30, 2025 | -$9.52M | -80.9% | -42.9% |
| March 31, 2025 | -$6.66M | -37.6% | -19.5% |
| September 30, 2024 | -$5.58M | -88.4% | -6.0% |
| June 30, 2024 | -$5.27M | — | -8.7% |
| March 31, 2024 | -$4.84M | -48.3% | -373.3% |
| December 31, 2023 | -$1.02M | +70.4% | +65.5% |
| September 30, 2023 | -$2.96M | +35.6% | +9.3% |
- TuHURA Biosciences, Inc./NV showed a decrease of -38.6% in Net Income compared to the prior fiscal year.
- Over the 2011–2025 period, TuHURA Biosciences, Inc./NV’s net income has declined by 2154.4% (from -$1.33 million to -$30.05 million).
- The most recent figure is from TuHURA Biosciences, Inc./NV’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: